Agenda

October 15-16, 2025 · Santa Clara, CA

View the full DeviceTalks West Innovation & Industry Forums agenda, 2025 speakers and more on Map Your Show.

View Agenda
Expand All +

  • October 15, 2024


  • October 16, 2024


  • October 17, 2024


  • Pre-registration is required.
    Where
    Mission City Ballroom B1

  • Exhibitor Move in from 9:00 AM - 5:00 PM
    Where
    Main Lobby

  • In this presentation, Mary Beth Kossuth will discuss the latest innovations in bioresorbable technology. She will also share insights and lessons learned from the multi-year development and approval process for a first-of-its-kind system for treating an unmet need in the peripheral anatomy. By attending this session, you will:

    Better understand the latest innovations in bioresorbable technology.
    Learn about the benefits of bioresorbable stents for addressing unmet patient needs, especially in the peripheral anatomy.
    Gain insights gleaned from a multi-year development and approval process for a first-of-its-kind medical device system.
    Interventional Technologies
    Where
    MCB M1

  • It’s no secret that technology reaches the masses when it is miniaturized to become smaller and more scalable. Could the same finally be true for soft tissue surgical robotics? In this session, John Murphy will share how Virtual Incision plans to leverage their MIRA Surgical System to bring RAS to any patient, anytime, anywhere.
    Surgical Robotics
    Where
    MCB B5

  • Shifamed is a highly specialized medical technology innovation hub that is building next-gen technologies to improve clinical standards and impact patient lives. This session will focus on Shifamed's newest portfolio company, Laza Medical, as they develop an intelligent ultrasound imaging solution with AI-driven robotic navigation for structural heart applications.
    Structural Heart
    Where
    MCB M3

  • Empower your sellers in the field to hit their quotas, close deals faster, and strengthen customer relationships with a single source of truth, real-time learning, and engaging buyer experiences with a purpose built enablement platform featuring real-time learning and engaging buyer experiences.
    Engineering Theater
    Where
    Engineering Theater

  • Upcoming regulatory changes and quality issues—PFAS, EtO sterilization, QMSR changes, LDTs, and cybersecurity requirements—will require large-scale remediation of your on-market products. In this session, you will learn effective strategies to manage and streamline your remediation program and to navigate complex business decisions that span multiple functions to ensure cohesive planning and successful compliance outcomes.
    Manufacturing & Materials
    Where
    MCB M1

  • Defining success can be variable for medical device companies, but once understood, and for all innovations, there are waypoints and markers where companies must consider and find best practices and protect their onward pathways. This panel will highlight some of the key points where medical device pioneers and even those established in the industry must understand the lay of the land and how to move forward including when to consult outside experts and on what topics. Our diverse panel of speakers include industry experts and attorneys who have first hand experience with intellectual property (when and how to protect), regulatory, legal (including understanding the relationship between process and potential liability risks) and commercial/financial. This panel will also highlight this using examples about how artificial intelligence and other aspects of the industry have changed and continue to change at warp speed.
    Innovation
    Where
    MCB B5

  • Companies that can identify longitudinal care journeys for patients with complex clinical histories have a tremendous advantage in the MedTech market. The ability to show hospitals where they are losing market share will transform sales reps into trusted advisors and win more business. See how MedTech companies are leveraging this data to pinpoint the right opportunities and improve patient outcomes.
    Innovation
    Where
    MCB M3

  • In the rapidly evolving landscape of medical devices, the more novel the applications become, the more creative we must be from a design, development, and testing perspective. For example, when developing complex catheters for robotic surgery, how do you approach design verification when the interventionalist is one step away from the catheter? During this engineering theater presentation, Kate Soojian, VitalPath Senior R&D Manager, will explore the unique challenges that engineers are facing on these next generation device projects and how to use an innovative problem-solving approach to ensure project success.

    Sponsored By
    Engineering Theater
    Where
    Engineering Theater

  • As the medical device industry becomes increasingly connected, robust cybersecurity is no longer optional—it's critical for market approval and patient safety. This session unveils the insider knowledge gained from Blue Goat Cyber's extensive work with hundreds of premarket submissions. Attendees will explore the most pressing cybersecurity challenges medical device manufacturers face and walk away with actionable strategies to strengthen their devices' security posture. From navigating complex regulatory landscapes to managing vulnerabilities and supply chain risks, this presentation offers a clear roadmap to mastering cybersecurity for successful market entry.

    Sponsored By
    Connected Health
    Where
    MCB M2

  • Coming soon
    Engineering Theater
    Where
    Engineering Theater

  • While it may be noble to develop robotics to help older demographics in society, companies small and large have good business reasons to do so. Roughly 10,000 Baby Boomers retire daily. These consumers not only have wants and needs, but they have worked their whole lives to create a nest egg to fund them. After 40-plus year careers, expectations are high, whether it’s demanding robotic-assisted surgery to get back on the golf course, an automated vacuum to take care of the house or a vehicle with the latest car with driver-assistance features to keep them independent. To make an impact (and a profit) designers must look beyond the mere need and consider user adoption and motivation if they hope to be successful in this increasingly competitive market. This talk will first define the size and opportunity this market provides robotics companies. Examples of how businesses are re-defining the way technical products and services are developed, marketed and adopted by older users will be presented. The challenges between the design team and consumer such as empathy, social, economic and other barriers will be discussed. The audience will leave with a greater appreciation for user adoption and an awareness of best practices for designing for older audiences. Hint: nobody ever asked for a wristlet incase ‘I have fallen and I can’t get up’. But if we work together, I promise we can build them what they do want.

    Sponsored By
    Engineering Theater
    Where
    Engineering Theater

  • When the Abbott MitraClip system was created, the world saw what was possible in repairing leaky mitral valves (mitral regurgitation). Building upon the proven success of MitraClip, a team of researchers, scientists and doctors specifically designed TriClip to treat the tricuspid valve's complex anatomy on the other side of the heart. Hear how harnessing the experience and technology from one solution led to developing a device for a condition that can severely impact quality of life -- but for which limited treatment options existed.
    Structural Heart
    Where
    MCB M3

  • Doug Goertzen, a co-founder of Kardium, will share the story of the short, 17- year adventure of starting and building a company focused on developing and commercializing one of the most advanced therapeutic medical devices ever - the Globe Pulsed Field ablation system designed to treat atrial fibrillation. Caution: The story may contain examples of extreme naiveté and hubris mixed with stubbornness.
    Interventional Technologies
    Where
    MCB M1

  • In this discussion, Moon Surgical's CTO David Noonan will explain how the surgical robotic start-up is helping to redefine the surgical robotics market by building a robot that helps hospitals and ASCs overcome crippling staff shortages while also collecting critical data.
    Surgical Robotics
    Where
    MCB B5

  • Biolinq's groundbreaking multi-analyte platform on a silicon chip is revolutionizing metabolic health monitoring. With microsensors embedded just below the skin, this innovative technology offers unparalleled simplicity and continuous small molecule biosensing, paving the way for healthier living and a new era in precision healthcare.
    Connected Health
    Where
    MCB M2

  • Join Brian Geisel, CEO of Geisel Software, to find out why we’re ditching reality to achieve the next level of autonomy. Through the lens of an Earth-shattering (or perhaps Mars-shattering?) NASA case study, you'll see firsthand how cutting-edge simulation environments are not just about testing theories but about creating solutions that work in the real world. As the world evolves, so do the challenges. Computer-Vision models are running out of training data, or operating in environments where there isn’t any today. For some models, the training data we need might take decades or centuries to gather, and achieving high accuracy is more critical—and difficult—than ever. Enter Synthetic Image Data. Discover how scene-based synthetic data is revolutionizing model training and validation with unprecedented depth, accuracy, and photorealism. This is making the. development process faster and more cost-effective while boosting the reliability and performance of autonomous systems in real-world scenarios. By the end of our session, you'll gain actionable insights on when to leverage synthetic data to improve model accuracy and to empower you to implement advanced simulation techniques in your own projects. Join us to transform your approach to autonomy and innovation.

    Sponsored By
    Engineering Theater
    Where
    Engineering Theater

  • Innovation thrives through collaboration, and Nissha Medical Technologies (a CDMO) is taking a novel approach by partnering with academic institutions, start-ups, and OEMs to navigate the complexities of technology integration early in the product development lifecycle. By investing in cornerstone novel technologies with start-ups and academia – such as navigation, miniaturization, and visualization – we aim to transform novel products into enabling technology platforms. Leveraging our trusted expertise in OEM design and manufacturing, we are bridging the gap to fast-track commercialization of minimally invasive surgical instruments and wearable technology. Join us for a panel discussion to explore how this unique development approach is addressing the unmet needs of both start-ups and OEMs.
    Surgical Robotics
    Where
    MCB B5

  • In the rapidly evolving world of robotics, data has emerged as a driving force behind innovation and success. This talk explores how to harness the power of robotics data to unlock actionable insights into your robots. We will discuss the fundamental types of data that are generated by robots, how the representation of that data can strengthen its meaning, how to generate insights into that data using analytics, among other topics. Rather you are an engineer or an executive, you will walk away from this talk with a deeper understanding of the importance of data, and how data can shape the way you operate your business.
    Engineering Theater
    Where
    Engineering Theater

  • The healthcare industry is undergoing a rapid transformation, driven by the need for better outcomes, reduced costs, and increased patient engagement. As healthcare systems are increasingly strained by rising demand, the challenge is to create an intelligent ecosystem that uses advanced technology—AI, machine learning, IoMT, and data analytics—to improve patient care, empower clinicians, and drive operational efficiency. This session will explore how Medical Device companies are creating world-class digital solutions that move beyond simple connectivity to true intelligence, shaping the future of healthcare.

    Key Takeaways:
    - Transforming Data into Actionable Insights: Learn how AI and data analytics can convert vast healthcare data into precise, real-time insights that enhance patient outcomes and clinician decision-making.
    - Improving Operational Efficiency: Discover how intelligent systems powered by IoMT and connected devices improve workflows, reduce errors, and enable clinicians to focus more on patient care.
    - Empowering Patient-Centered Care: See how digital platforms, wearables, and mobile apps engage patients in their own care, driving better outcomes through personalized experiences.
    - Collaborating for Innovation: Explore the role of strategic partnerships in accelerating digital transformation in healthcare and driving the creation of intelligent healthcare ecosystems.
    - Ensuring Scalability and Compliance: Understand how GlobalLogic’s expertise in regulated software development ensures that intelligent healthcare systems are secure, compliant, and scalable.
    Connected Health
    Where
    MCB M1

  • We will discuss some of the legal issues with AI-enabled medtech, and how to navigate those issues in contracts, partnering, and fundraising.
    Innovation
    Where
    MCB M3

  • In industries where complex hardware and rapid iteration are key, effective product lifecycle management (PLM) is essential to staying competitive. This presentation will explore how cloud-based PLM solutions streamline processes, improve collaboration, and accelerate time to market across sectors like robotics and medical devices. As an innovator in this space, Bomello will share insights on how companies can enhance their workflows, reduce costly errors, and drive faster innovation. Join us to learn about the future of PLM and its transformative impact on hardware development!

    Sponsored By
    Engineering Theater
    Where
    Engineering Theater

  • Andy Pierce, Stryker’s group president of MedSurg and Neurotechnology, will share how Stryker harnesses internal and external innovation to collaborate with its customers to make healthcare better.
    Interventional Technologies
    Keynote
    Neurotechnology
    Where
    MCB B5

  • Vision technology is very advanced nowadays and has been addressed in detail in the past. With the help of AI and its advancement, the feedback from vision has enabled robots to be able to recognize any objects' shape, location in space and convert it to useful information and act "smart" when in manipulation.
    Engineering Theater
    Innovation
    Where
    Engineering Theater

  • Pre-registration is required.
    Where
    MCB B1

  • Join us for an exclusive glimpse into the groundbreaking innovations set to transform MedTech! We’ll delve into how AI is revolutionizing medical devices to deliver patient-centric care and enhance healthcare access. Discover how these innovations are revealing the unseen, addressing data scarcity, and enabling real-time insights and seamless automation, all while accelerating time to market and development, and pioneering new business models that are reshaping the industry.
    Connected Health
    Keynote
    Where
    MCB B5

  • In classic first-mover fashion, Shockwave Medical created and now leads the IVL marketplace. Now the company is helping to build Johnson & Johnson Medtech's interventional portfolio and is making its next play with the Reducer technology. Shockwave Chief Medical Officer Dr. Nick West, an interventional cardiologist, will explain how IVL has achieved the growth it has to-date, where it is exploring new roles for IVL in the near future, as well as new opportunities on the horizon.
    Interventional Technologies
    Where
    MCB M1

  • Among the more critical applications for neurotech is bringing relief to people who are literally suffering from chronic pain. In this discussion, leaders from Boston Scientific will break down the power behind the the Intracept Procedure, which uses targeted RF energy to ablate the basivertebral nerve. The technique was developed by Relievant, which secured FDA approval to treat vertebrogenic pain. Boston Scientific acquired the company last year.
    Neurotechnology
    Where
    MCB M3

  • This discussion will focus on the necessity of moving beyond uniform device design in favor of approaches that consider anatomical and physiological differences to ensure medical devices are as varied as the patients they serve. Focusing on conditions that impact all patient populations, this panel will challenge the status quo by addressing what we’re doing right and what we still need to do to ensure equity in design and treatment, ultimately improving outcomes across all patient groups.
    Structural Heart
    Women's Health
    Where
    MCB B5

  • Traditional medical device development often faces significant challenges, including time-consuming animal testing, high costs, and ethical concerns. In Silico Medicine offers a transformative solution by leveraging advanced computational models and simulations to create virtual human environments. This innovative approach enables researchers to conduct comprehensive and controlled testing, exploring a wider range of scenarios than would be possible with physical experiments.

    By replacing physical testing with digital simulations, we can significantly reduce development time, costs, and ethical concerns. In Silico Medicine empowers researchers to optimize device design, enhance safety, and accelerate time-to-market. This revolutionary technology is poised to revolutionize the medical device development process, bringing innovative solutions to patients more quickly and efficiently.
    Engineering Theater
    Where
    Engineering Theater

  • The recent sale of Edwards Lifesciences’ Critical Care reflects the company’s sharpened focus as a structural heart innovator. With significant opportunities within its TAVR, TMTT and Surgical businesses, the company is also focusing on supporting patients in need of therapies to treat aortic regurgitation, non-valvular structural heart disease and heart failure through implantable technologies. In this session, attendees will hear more about the company’s focus, its patient-focused culture and its expansion of leadership in structural heart innovation.
    Structural Heart
    Where
    MCB B5

  • In the first phase, surgical robot tools sharpened surgeon precision. Next, data is measuring and improving performance. But for surgical robotics to fulfill its overriding mission - access to top quality care - surgeons must be able to perform procedures remotely over long-distances. Sovato executives will explain how the company is building a system upon which that can happen
    Connected Health
    Surgical Robotics
    Where
    MCB M2

  • In this presentation, Byron Izquierdo will discuss how to develop simple, accessible, and commercially viable robotic solutions tailored specifically for emerging economies. These solutions are designed for individuals with lower levels of education, making them easy to implement without the need for advanced technical skills. We will explore success stories in sectors such as education, agriculture, and small-scale industries, where robotics technology has proven transformative. Additionally, we will analyze the key technical features that have made our solutions accessible and user-friendly, ranging from educational kits to industrial robots adapted to the limited resources and local needs of these markets.

    Sponsored By
    Engineering Theater
    Where
    Engineering Theater

  • Join MedTech industry peers for an hour of networking, engagement, and mentorship (and food and drink, of course). Find a mentor, reach out to a new contact, reconnect, and help foster a movement that needs more female leadership at all levels.

    Featuring a fireside chat with Yj Oh, SVP, Surgical US Sales and Marketing at Edwards Lifesciences.

    Thank you to our Sponsors: Aptyx, Capstan Medical, GlobalLogic, Integer Holdings, and Westfall Technik!

    Ticket required; Pre-registration is required and spots are limited.

    Sponsored By




    Women's Health
    Where
    MCB M1

  •  
    Where
    Exhibit Hall A/B

  • We have seen a surge in robotics startups in the last few years, but this has not necessarily translated to increased automation. Factories remain relatively devoid of robots, with human-operated vehicles dominating material movement. In this talk, we will discuss challenges across manufacturing functions in automating workflows - fear of increase in production backlogs, cybersecurity concerns, safety compliance. We will also present Ati's efforts in tackling these problems while simultaneously overcoming the long-tail of edge cases seen in real-life environments.

    Sponsored By
    Engineering Theater
    Where
    Engineering Theater

  • A view into Medtronic’s journey to regulatory approval for the Symplicity Spyral™ renal denervation system. Jason Weidman will share more about the power of persistence with Medtronic's renal denervation journey. Although the path to FDA approval was long and sometimes challenging, it was well worth the wait - especially for those patients who suffer from uncontrolled high blood pressure.
    Interventional Technologies
    Where
    MCB B5

  • Patients with suspected prostate cancer often face a journey marked by uncertainty and the risk of inaccurate risk profiling. Effective management of prostate cancer necessitates seamless integration between radiology, urology, and pathology. This panel session explores how the latest Med Tech in hardware and software can bridge departmental silos to enhance the patient journey from initial assessment to diagnosis and treatment planning. This session will demonstrate how advanced solutions address these challenges by providing a comprehensive, connected care framework.

    Participants will learn about the pivotal role of high-resolution MR imaging and advanced quantification tools in radiology that facilitate accurate lesion assessment and efficient biopsy sampling. We will delve into how streamlined workflows between radiology and urology improve tumor targeting and biopsy precision, while digital pathology integrates seamlessly for faster and more accurate diagnoses, and emphasizing how digital solutions increase biopsy accuracy.
    Key learning objectives include:
    • Understanding the technological advancements that connect radiology, urology, and pathology.
    • Exploring how these technologies reduce patient stress and improve diagnostic accuracy.
    • Evaluating the impact of AI and digital pathology on workflow efficiency and diagnostic turnaround time. By the end of the session, attendees will gain insights into optimizing patient care through integrated, technology-driven approaches.
    Connected Health
    Where
    MCB M2

  • An exoskeleton equipped with a brain-computer interface is helping stroke patients increase functional independence and accelerate motor recovery. In this discussion, representatives from Neurolutions - the creator of IpsiHand - and Kandu Health - tech-enabled healthcare services company created to help people who have had strokes - will give details on the technology and their partnership. Earlier this year, Neurolutions received a new code from CMS, setting a new benchmark for thought-activated controlled devices.
    Neurotechnology
    Where
    MCB M3

  • This session will delve into the intricate process of miniaturization that powers Endiatx' revolutionary motorized capsule endoscope, PillBot, offering unprecedented insights into the challenges our engineers have undergone developing micro-robotics technology, from initial concept to final product. Attendees will better understand the technical and creative efforts that drive our mission to transform medical diagnostics.

    This engineering panel will consist of experts in the fields of electrical engineering, computer engineering, software engineering, mechanical engineering, manufacturing engineering, and advanced artificial intelligence (AI). Modern biomedical engineering of tomorrow must include all of these disciplines and more if we are to bring advanced diagnostics to patients worldwide and revolutionize healthcare delivery.
    Surgical Robotics
    Where
    MCB M3

  • PillBot™, the AI-enabled motorized pill camera that swims in the water-filled stomach, will be presented by Endiatx Co-founder and CEO Torrey Smith. PillBot™, the first device in the exciting new category of micro-robotics in the human body, will conclude FDA trials in 2025. Equipped with AI for telemedicine-enabled movement and diagnostics, PillBot™ will dramatically reduce barriers to GI care and prevention.
    Keynote
    Surgical Robotics
    Where
    Theater

  • Being able to embrace new ideas or approaches that create uncertainty may mean the difference between industry disruption or stagnation. More importantly, knowing the difference between risk and uncertainty may mean the difference between bringing meaningful therapies to patients or letting a need remain unmet.

    In this keynote interview, Adam Elsesser, CEO of Penumbra, discusses the key factors to driving the medical device industry forward:

    - Rethink the structure of in research & development, by allowing teams the freedom to work through ideas unencumbered by stringent project schedules
    - Break free from rigid/established hierarchy to empower contributions from wider teams and employees as it could lead to revolutionary product ideas
    - Value incremental innovation and iteration to optimize your products and expand their impact
    Interventional Technologies
    Keynote
    Neurotechnology
    Where
    MCB B5



DeviceTalks is a conversation among leaders, an evening for an exchange of ideas, insight and contacts among the pioneers of the medical technology industry.
Facebook Linkedin X-twitter Youtube
Life Science Network
Resources

Subscribe to MassDevice
Advertise with us

For registration or logistic questions, contact events@arrowfly.com

Sponsorship Opportunities

Colleen Sepich
Events Sales Director
csepich@arrowfly.com
857-260-1360

Heather Herbert
Event Sales Manager
hherbert@arrowfly.com
512-760-0570

Copyright © 2026 Arrowfly LLC. All Rights Reserved.